A Mayo Clinic BioPharma Diagnostics engagement offers partners access to Mayo Clinic Laboratories’ robust library of hematology evaluations. Our extensive testing menu features diagnostic, prognostic, and monitoring assays across the spectrum of hematological disorders. From state-of-the-art MALDI-TOF mass spectrometry (MASS-FIX) evaluations for the detection of monoclonal protein disorders, to comprehensive fluorescence in-situ hybridization (FISH) panels for personalized insights on lymphoma and myeloid neoplasms, our assays offer partners the tools needed to expediate clinical trial and drug development solutions.
Mayo Clinic Laboratories’ hematology testing laboratories are led by board-certified hematologists and hematopathologists who focus on molecular diagnostics and prognostics of hematologic disorders. Our expert-backed tests are designed to improve outcomes, increase efficiency, and decrease costs.
A Mayo Clinic BioPharma Diagnostics collaboration enables access to the hematological disease testing capabilities of Mayo Clinic Laboratories, including:
Learn more about clinically approved hematology testing from Mayo Clinic Laboratories.